[1]李强,王茂强,宋鹏,等.内乳动脉参与肝癌供血的介入治疗[J].介入放射学杂志,2007,(12):816.
　LI Qiang,WANG Mao-qiang,SONG Peng,et al.Treating hepatic carcinoma with internal mammary artery blood supply through transcatheter arterial chemoembolization[J].journal interventional radiology,2007,(12):816.
点击复制

内乳动脉参与肝癌供血的介入治疗()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年12期
页码:
816
栏目:
肿瘤介入
出版日期:
2007-12-15

文章信息/Info

Title:
Treating hepatic carcinoma with internal mammary artery blood supply through transcatheter arterial chemoembolization
作者:
李强; 王茂强; 宋鹏; 等
１００８５３北京中国人民解放军总医院介入医学科
Author(s):
LI Qiang; WANG Mao-qiang; SONG Peng; DUAN Feng; LIU Feng-yong．
Department of Interventional Radiology，General Hospital of PLA，Beijing１００８５３，China
关键词:
肝癌; 内乳动脉; 栓塞化疗; 动脉造影; 介入治疗
分类号:
R７３５.７
文献标志码:
A
摘要:
目的探讨内乳动脉（IMA）对肝癌的供血及其介入栓塞在肝癌治疗中的价值。评价经导管作IMA栓塞化疗的安全性和效果。方法对８６例经血管造影确认有IMA参与肝癌供血患者进行TACE。全部病例均曾行TACE治疗，１６例曾行经皮微波固化治疗，４例有外科手术史。术前行CT或MRI平扫及增强扫描，术中行IMA造影，在确认供血范围后将导管超选择至供血支，先用碘油－抗癌乳剂栓塞肿瘤末梢血管，然后注入明胶海绵碎粒或PVA颗粒，并摄肝区平片，观察肝区碘油分布及术后临床经过、相关实验室检查和影像学表现，并与血管造影进行对照分析。结果本组病例病灶均为巨块型，均位于肝脏前部接近膈肌或（和）肝包膜。５７例累及S４、S５、S８段，２９例累及S５、S７、S８。８０例为右侧IMA参与供血，５例为左侧IMA参与供血，１例为双侧IMA参与供血。８６例参与供血的IMA栓塞全部成功。未出现皮肤损伤并发症。结论IMA参与肿瘤供血一般多见于过去曾多次行TACE的巨块型肝癌患者，且肿块位于肝前部。IMA TACE方法安全，技术可行，但应警惕皮肤损伤并发症。

参考文献/References:

［１］王茂强，王仲朴，刘风永，等．膈下动脉参与肝肿瘤供血的介入治疗研究［J］．中国医学影像技术，２００３，１９：１５５１-１５５３．
［２］Barone M，Ettorre GC，Ladisa R，et al．Transcatheter arterial chemoembolization（TACE）in treatment of hepatocellular carci-noma［J］．Hepatogastroenterology，２００３，５０：１８３-１８７．
［３］Tanabe N，Iwasaki T，Chida N，et al．Hepatocellular carcinomas supplied by inferior phrenic arteries［J］．Acta Radiol，１９９８，３９：４４３-４４６．
［４］Chung JW，Park JH，Han JK，et al．Transcatheter oily chemo-embolization of the inferior phrenic artery in hepatocellular carcinoma：the safety and potential therapeutic role［J］．J Vasc Interv Radiol，１９９８，９：４９５-５００．
［５］Michels NA．Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis［J］．Cancer，１９５３，６：７０８-７２４．
［６］Ohishi H，Ohue S，Katsuragi M，et al．Angiographic demonstra-tion of the collateral circulation to the liver after arterial embolization of hepatocellular carcinoma［J］．Jpn J Clin Radiol，１９８２，２７：１２３５-１２４１．
［７］Charnsangavej C，Chuang VP，Wallace S，et al．Angiographic classification of hepatic arterial collaterals［J］．Radiology，１９８２，１４４：４８５-４９４．
［８］伊藤茂树，矶村高之，石口恒男，他．肝动脉闭塞を伴う再凳肝细胞癌に对すゐ肝外侧副血行路を介する动脉栓塞术の检讨［J］．臨床放射，１９９４，３９：２４９
［９］王茂强，张金山，高育璈．胸廓内动脉参与肝脏肿瘤供血的影像表现与介入治疗（附６例报告）［J］．临床放射学杂志，１９９８，１７：４７-４９．
［１０］Okazaki M，Higashihara H，Nozaki Y，et al．Collateral transca-theter chemoembolization for the treatment of hepatocellular carcinoma［J］．Jpn J Intervent Radiol，１９９５，１０：２７３-２７８．
［１１］Kim JH，Chung JW，Han JK，et al．Transcatheter arterial emb-olization of the internal mammary artery in hepatocellular carcinoma［J］．J Vasc Interv Radiol１９９５，６：７１-７７．
［１２］Kanetsuk I，Hori A，Ohshiro K，et al．Left lobe recurrent hepatocellular carcinoma treated with lipiodol-TAE via the left internal mammary artery［J］．Cardiovasc Intervent Radiol，１９９７，２０：３８７-３８９．
［１３］Miyayama S，Matsui O，Taki K，et al．Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery：anatomical and technical analysis［J］．J Vasc Interv Radiol，２００４，１５：８１５-８２３．
［１４］Kwon JW，Chung JW，Song SY，et al．Transcatheter arterial chemoembolization for hepatocellular carcinomas in patients with celiac axis occlusion［J］．J Vasc Interv Radiol，２００２，１３：６８９-６９４．

相似文献/References:

[1]曹海利,孟巍,白彬.肝癌基因治疗研究新进展[J].介入放射学杂志,2008,(05):375.
　CAO Haili,MENG Wei,BAI Bin.New progress in research of gene therapy for hepatocellular carcinoma[J].journal interventional radiology,2008,(12):375.
[2]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
　LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].journal interventional radiology,2008,(12):514.
[3]杨伟洪,刘鹏程,梁珊瑚,等.多层螺旋CT血管造影在判断肝癌寄生供血中的价值[J].介入放射学杂志,2008,(09):654.
　YANG Weihong,LIU Pengchen g,LIANG Shanhu,et al.Evaluation of MSCTA for parasitic blood supply in hepatic carcinoma[J].journal interventional radiology,2008,(12):654.
[4]张茵,周兵,许秀芳,等.肝动脉化疗栓塞治疗原发性肝癌存活２０年一例[J].介入放射学杂志,2008,(09):684.
　ZHANG Yin,ZHOU Bing,XU Xiufang,et al.Survival more than２０years after transarterial chemical embolization for hepatocellular carcinoma：A case report[J].journal interventional radiology,2008,(12):684.
[5]官泳松,贺庆.肝癌介入治疗中应用p５３的几个要点[J].介入放射学杂志,2008,(11):761.
　GUAN Yongsong,HE Qing.Essentials in clinical application of p５３for tumors intervention－example of liver cancer[J].journal interventional radiology,2008,(12):761.
[6]肖运平,肖恩华.介入治疗在防治肝癌术后复发中的作用及进展[J].介入放射学杂志,2008,(11):831.
　XIAO Yunping,XIAO Enhua.The role and progress of interventional therapy in the prevention and treatment of postoperative hepatocellular carcinoma recurrence[J].journal interventional radiology,2008,(12):831.
[7]史震山,陈自谦,杨熙章,等.原发性大肝癌患者TACE后S－腺苷蛋氨酸的护肝作用[J].介入放射学杂志,2008,(11):790.
　SHI Zhenshan,CHEN Ziqian,YANG Xizhang,et al.The clinical study on the liver－protection of S－adenosy－methionine in large hepatocellular carcinoma patients after TACE[J].journal interventional radiology,2008,(12):790.
[8]王耀普,杨康健,赵思源,等.兔肝癌模型的改良接种及其DSA影像分析[J].介入放射学杂志,2010,(03):214.
　WANG Yaopu,YANG Kangjian,ZHAO Siyuan,et al.The modified inoculation method for the preparation of rabbit VX２hepatic carcinoma model and DSA imagining observation[J].journal interventional radiology,2010,(12):214.
[9]贺洪德,贺晶,罗中华,等.肝动脉化疗栓塞联合门静脉栓塞治疗中晚期肝癌的疗效评价[J].介入放射学杂志,2010,(03):191.
　HE Hongde,HE Jing,LUO Zhonghua,et al.Evaluation of the therapeutic effect of hepatic arterial chemoembolization combined with portal chemoembolization for advanced hepatic carcinomas[J].journal interventional radiology,2010,(12):191.
[10]李广琪,曹玮,李超,等.肝动脉热灌注对兔肝VX２肿瘤及正常肝组织血管渗透性功能的作用[J].介入放射学杂志,2010,(03):217.
　LI Guangqi,CAO Wei,LI Chao,et al.Influence of hepatic artery thermotherapy on the vascular permeability of hepatic tumor tissue and normal liver tissue in VX２tumor－bearing rabbits[J].journal interventional radiology,2010,(12):217.

备注/Memo

备注/Memo:
收稿日期：２００７-０７-３０
更新日期/Last Update: 2007-12-15